Nxstage Medical, Inc.

Lawrence, MA Part of Fresenius Medical Care Holdings Inc.

UEI
WTE4T3GFAGU3
CAGE
4ELZ9
Primary NAICS
339112 Surgical and Medical Instrument Manufacturing
SAM.gov registration
Active through

Company facts

FY2025 rankings

Its parent company, Fresenius Medical Care Holdings Inc., ranks #9 at the Department of Veterans Affairs

Self-certified in SAM.gov
  • Foreign Owned
  • For Profit Organization
  • Manufacturer of Goods
Entity structure
Corporate Entity (Not Tax Exempt)
Corporate family
SAM.gov registration date
Physical address
350 Merrimack St, Lawrence, MA 01843, USA
Founded
1996
Employees
100K+
Estimated annual revenue
$10B+
Industry
  1. Health Care
  2. Health Care Equipment & Services
  3. Health Care Providers & Services
  4. Health Care Services
SIC code
80 Health Services

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract obligations by fiscal year

Fiscal year Obligated
FY2027 To date $0
FY2026 $90,400
FY2025 $110,731
FY2024 $18,743
FY2023 $249,234

Top agencies by obligations

Rank Agency Obligated, FY2026–FY2027 Share
1 Department of Veterans Affairs $58,000
2 Defense Health Agency $32,400

Contract vehicles

Contract awards

Latest 5 listed here. See the rest on GovTribe.

Similar vendors

About the company

Nxstage Medical, Inc., a foreign-owned manufacturer of dialysis equipment and continuous renal replacement therapy (CRRT) systems headquartered in Lawrence, Massachusetts, operates as a prime contractor supplying medical devices and consumables to the Department of Veterans Affairs, Department of Defense, and the Army Medical Command on full-and-open, non-set-aside basis. Nxstage is a subsidiary of Fresenius Medical Care Holdings Inc., a multinational healthcare provider.

Nxstage's federal footprint centers on hemodialysis systems, CRRT equipment, dialysis consumables (cartridges, dialysate solutions, bicarbonate), and associated maintenance services. Representative work includes a $214.2 million dialysis service and preventive maintenance order from Veterans Integrated Service Network 6 (VISN 6) running through September 2026; a $113 thousand on-site preventive maintenance contract with the Defense Health Agency for equipment at Bethesda, Maryland, through September 2029; a $162 thousand annual preventive maintenance order from the Defense Health Agency for hemodialysis units at JBSA FT SAM Houston, Texas, through November 2027; and a $97.3 thousand emergency CRRT machine delivery under the VA's $50 million Health Administration Equipment Life Cycle Management Program (VHA ELCM). Nxstage also holds two indefinite delivery vehicles: a $3.125 million Federal Supply Schedule contract (Medical Equipment and Supplies, FSS-65-II-A) awarded by VISN 12 through January 2029, and a now-closed $50 million multiple-award IDIQ under VHA ELCM that standardized dialysis equipment across over 150 VA medical facilities nationwide.

Customer concentration is pronounced within the VA system and DoD medical enterprise. The top five customers by award count account for 53% of recent awards: the Army Medical Command leads with 55 awards and $17.3 million combined potential value, followed by Defense Logistics Agency Troop Support Medical (48 awards, $550 thousand), VISN 6 (30 awards, $1.5 million), VISN 12 (28 awards, $5.6 million), and the Defense Health Agency (22 awards, $1.1 million). By dollar value, the Army Medical Command and VISN 12 dominate, accounting for two-thirds of the top-five customers' combined potential value. Nxstage serves 28 distinct federal agencies across its award portfolio.

Activity has declined measurably. Awards per year dropped from 11 in 2022 to 3 in 2023, 3 in 2024, 2 in 2025, and 1 through the first two months of 2026, indicating reduced procurement velocity. The combined potential value across 347 prime awards totals $84.9 million, with only $12.1 million obligated (14% realization rate), reflecting the long-tail nature of indefinite delivery vehicles and task-order-based contracting. Three awards worth $307 thousand combined face ultimate completion within the next twenty-four months, creating minimal recompete exposure. Nxstage's work concentrates in Surgical and Medical Instrument Manufacturing (143 awards, primary NAICS) and Electromedical and Electrotherapeutic Apparatus Manufacturing (64 awards), with Medical And Surgical Instruments, Equipment, And Supplies (PSC code) representing 203 of the 347 awards.

Quick answers

Is Nxstage Medical, Inc. registered in SAM.gov?

Yes. Nxstage Medical, Inc.'s SAM.gov registration is active through May 5, 2027.

Which contract vehicles does Nxstage Medical, Inc. hold?

Nxstage Medical, Inc. holds a place on 2 federal contract vehicles, including FSS-65-II-A and VHA ELCM.

How much has Nxstage Medical, Inc. received in federal contracts?

Federal contracts obligated $110,731 to Nxstage Medical, Inc. in fiscal year 2025 and $469,107 in fiscal years 2023 through 2027.

How does Nxstage Medical, Inc. rank among federal contractors?

Nxstage Medical, Inc.'s parent company, Fresenius Medical Care Holdings Inc., ranked #9 at the Department of Veterans Affairs in FY2025.

What is Nxstage Medical, Inc.'s most recent federal award?

Nxstage Medical, Inc.'s most recent federal contract award is Nxstage system one maintenance for RMR (36C25926P0570), from Veterans Integrated Service Network 19 (VHA), on August 1, 2026.

On GovTribe

See Nxstage Medical, Inc.'s full federal record

  • Federal contract awards
  • IDV awards
  • Contract vehicles
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors